Springvest
VC Fund
Helsinki, Finland
Springvest is a listed growth equity investor connecting Finnish technology companies with both domestic and international capital. We typically raise €5–12 million rounds from our Finnish investor base and lead larger rounds of up to €50 million together with international co-investors. We remain a committed minority shareholder in every company we back.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Springvest invests in
Stages Springvest invests in
Countries Springvest invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.6M–$7.6M
- Series A
- $3.6M–$53M
- Venture - Series Unknown
- $4.7M–$31M
Investment Focus
Industry
- Biotechnology 7 (29%)
- Health Care 5 (21%)
- Medical 3 (13%)
- Analytics 3 (13%)
- Artificial Intelligence 3 (13%)
Stage
- Series A 12 (50%)
- Venture - Series Unknown 3 (13%)
- Seed 2 (8%)
- Series B 1 (4%)
- Series C 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aki Soudunsaari
CEO
|
CEO | Total investments: 2 | Find email | |
|
Jouni Mäkelä
Investment Director
|
Investment Director | Total investments: 1 | Find email | |
|
Markku Jussila
Co-Founder & Director
|
Co-Founder & Director | Total investments: 0 | Find email | |
Päivi Malinen
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivityreaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society. | $31.4M / Venture - Series Unknown / Oct 12, 2026 | ||
| MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location. | $3.9M / Equity Crowdfunding / Nov 06, 2025 | ||
| Founded in 2019 and headquartered in Helsinki, Finland, ReOrbit is a fast-growing European space technology company that manufactures sovereign satellites and connected systems for national security. Our technologies provide independent control of critical space assets and enable secure communications for both military and civilian use. Throughlong-term partnerships and knowledge transfer, we ensure our customers achieve and maintain strategic autonomy.With offices across multiple countries, we bring together a diverse team of experts who bring extensive industry experience and technical excellence to our operations. As we continue to expand, we are opening new locations worldwide and are always on the lookout for talented, ambitious individuals to join our journey. | $53M / Series A / Sep 08, 2025 | ||
| Sustainable high-quality protein and lipid ingredients for the industry from local raw materials | $29.5M / Venture - Series Unknown / May 27, 2025 | ||
| Sustainable high-quality protein and lipid ingredients for the industry from local raw materials | $6.8M / Series A / Oct 11, 2024 | ||
| Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes. | $8.6M / Series B / Apr 26, 2024 | ||
| Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivityreaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society. | $12.9M / Venture - Series Unknown / Feb 08, 2024 | ||
| Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes. | $8.7M / Series B / Nov 16, 2023 | ||
| Kuva Space improves life on Earth by using the world's most extensive hyperspectral satellite constellation and artificial intelligence. The company's GREEN DATA® platform will address some of the world's most important concerns, including climate change, disaster response, food demand, and safety and security. | $17.6M / Series A / Nov 02, 2023 | ||
| MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location. | $1.6M / Seed / May 03, 2023 | ||
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Springvest invest in?
Springvest invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Venture - Series Unknown stage. Most of the 24 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Springvest invest in?
Springvest typically joins rounds of $1.6M–$7.6M at Seed, $3.6M–$53M at Series A and $4.7M–$31M at Venture - Series Unknown. These are whole funding-round sizes, not Springvest's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Springvest took part in.
How do I contact Springvest?
Public channels for Springvest include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Springvest?
The team at Springvest includes Aki Soudunsaari (CEO), Jouni Mäkelä (Investment Director) and Markku Jussila (Co-Founder & Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
